Measured prostate‐specific antigen (PSA) levels are correlated with the lipid profile and ANGPTL3 levels in men at risk for prostate cancer but no longer display this correlation in men diagnosed with prostate cancer. Here, ANGPTL3 is linked to prostate carcinoma.